Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Responsibilities and generic drugs]

P Joly1

  • 1Fondation pour la Recherche Médicale, Paris.

Bulletin De L'Academie Nationale De Medecine
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Generic drugs offer competition post-patent but may not lower costs in high-volume, low-price markets like France. Vigilance regarding production quality and prescription freedom is crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal magneto-optical Kerr effect (MOKE) magnetometry integrated within synchrotron-based diffraction for in situ magneto-mechanical investigations.

The Review of scientific instruments·2026
Same author

Pellagra in anorexia nervosa.

Annales de dermatologie et de venereologie·2026
Same author

French national protocol for diagnosis and management of pemphigoid gestationis.

Annales de dermatologie et de venereologie·2026
Same author

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Prevalence of sleep disorders in patients with bullous pemphigoid.

Annales de dermatologie et de venereologie·2026
Same author

Risk of persistent hypogammaglobulinaemia in children with autoimmune bullous dermatoses treated with rituximab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Area of Science:

  • Pharmaceutical Economics
  • Drug Policy

Context:

  • Pharmaceutical market dynamics and patent expiration.
  • Healthcare systems with high drug consumption and low average prices, such as France.

Purpose:

  • To evaluate the economic and healthcare impact of generic drugs in specific market conditions.
  • To assess the role of generics in addressing pharmaceutical consumption challenges.

Summary:

  • Generic drug introduction is driven by price competition after patent expiry, benefiting high-cost markets.
  • In France, characterized by high drug volume and low average prices, generics have limited impact on overall consumption.
  • Concerns exist regarding production quality and potential threats to physician prescription freedom.

Impact:

Related Experiment Videos

  • Highlights the limited economic utility of generics in certain national healthcare systems.
  • Underscores the need for vigilance on drug quality and the preservation of independent medical prescription.
  • Suggests potential significant consequences for pharmaceutical research and development funding.